Centum Electronics Ltd (CENTUM) - ECMS Capex Approval Analysis

Analysis Date: 18 August 2026
Market Cap: ₹5,058 Cr | Price: ₹3,427.2 | TTM Revenue: ₹1,072 Cr

1. Catalyst & Ramp-Aware Arithmetic

Centum Electronics received approval under the Electronics Components Manufacturing Scheme (ECMS) for a proposed capital outlay of ₹106 Cr over 5 years targeting Transducers and Filters.

• Capex Run-Rate: ₹106 Cr spread over 5 years equates to ~₹21.2 Cr/year (~2.0% of TTM revenue per annum).
• Expected Asset Turn: Specialised electronic component manufacturing typically delivers fixed-asset turns of 1.8x - 2.2x at full utilisation.
• Steady-State Revenue Addition: At 2.0x asset turn, peak revenue from this capex is estimated at ~₹210 Cr annually (~19.5% of TTM revenue).
• Ramp Profile:
• Year 1 (FY27): Initial engineering & line setup; revenue impact negligible (~₹15-20 Cr or ~1.5% uplift).
• Year 3 (FY29): Partial commercialisation (~₹90-110 Cr uplift).
• Year 5 (FY31): Full ramp (~₹200-210 Cr steady-state uplift).
• Margin & EPS Impact: Component lines typically command standalone-level EBITDA margins (13-15%) and PAT margins of 7-8%. Steady-state PAT addition is estimated at ₹15-17 Cr, adding ~₹10.5 to EPS on current share base of ~1.48 Cr shares.

2. Industry Context & Multibagger Quality Screen

• Industry: Electronics Components / Defence & Aerospace EMS.
• Capital Intensity & Execution: Medium capital intensity. High technical barriers for qualification with Indian tri-services and space agencies, but manageable execution risk given Centum's established BTS (Build-to-Spec) heritage.
• Structural Shifts: The company deconsolidated its loss-making European subsidiaries (Centum T&S Group) in Q1 FY27, which had previously depressed consolidated margins. While Q1 FY27 PAT showed ₹105.5 Cr, ₹81.2 Cr of this was a one-off accounting gain on deconsolidation, with core standalone quarterly PAT around ₹13.5 Cr (~₹55-60 Cr normalised annualised run-rate).
• Balance Sheet Strength: D/E stands at a comfortable 0.28 (Debt: ₹123 Cr, Net Worth: ₹432 Cr), giving adequate balance sheet headroom for the ₹106 Cr capex outlay.

3. Valuation & Scenario Calibration

• Trailing Context: Stock trades at P/E of 61.2x and P/B of 11.7x against a peer median P/E of 53.1x. Current valuation already prices in the European turnaround and high growth expectations.
• Bull Case (+68% upside): Accelerated ramp in defence electronics, operating leverage pushing standalone margins to >15%, and seamless ECMS execution driving FY29 EPS to ₹85+ at 55x multiple (Target Price: ~₹4,675).
• Base Case (+32% upside): Steady execution over 3-4 years, core FY29 EPS reaching ₹65 at 50x multiple (Target Price: ~₹3,250 - ₹3,600 from current levels factoring earnings growth catching up to valuation).
• Bear Case (-28% downside): Valuation de-rating if core execution stalls, delays in qualification of Transducers/Filters, or working capital stretch (Target Price: ~₹2,470 at 38x FY28 normalised EPS).

4. Verdict Rationale

While the ECMS approval validates Centum's high-tech manufacturing credentials, the ₹106 Cr capex is a multi-year incremental project rather than an immediate transformational event. The structural thesis is supported by the French subsidiary exit and a ₹1,797 Cr order book, placing Centum in the POSSIBLE multibagger category, tempered by elevated starting valuation.

Centum Electronics (CENTUM) - Investment & Growth Analysis

1. Industry Context & Execution Assessment

• Capital Intensity: HIGH. Electronic manufacturing facilities targeting high-reliability defence and space applications require specialized SMT lines, environmental testing chambers, and cleanroom facilities.
• Execution Dynamics: Defense hardware production carries strict qualification standards. Greenfield expansion requires ~12-18 months of facility setup, followed by 6-12 months of client audits and prototype testing before full volume production.
• Industry CAGR: The Indian defence electronics and Strategic Electronics Business Unit (SEBU) market is expected to grow at 18-22% CAGR through FY30, supported by indigenization programs.

2. Ramp-Aware Catalyst & Financial Math

• Proposed Capex: ₹500 Cr over 4 years (~₹125 Cr/year).
• Revenue Conversion Potential: Assuming an asset turnover ratio of ~2.2x for BTS/SEBU high-tech manufacturing, the fully ramped facility could add ~₹1,100 Cr in steady-state annual revenue.
• Timeline & Revenue Uplift:
• Year 1 (FY27): Construction & initial trial runs. Revenue uplift: ~3.0% (~₹35 Cr).
• Steady-State (FY30-31): Fully operational. Revenue uplift: ~96.0% (~₹1,100 Cr over current TTM revenue of ₹1,141 Cr).
• Earnings Impact:
• Standalone core business generated ~₹75 Cr in normalized PAT in FY26 (ex-European subsidiary write-offs).
• At steady-state, incremental ₹1,100 Cr revenue at an estimated 16% OPM yields ₹176 Cr incremental EBITDA.
• Less ~₹50 Cr in interest and depreciation, incremental PBT is ~₹126 Cr -> incremental PAT (at 25% tax) ~₹94.5 Cr.
• Total normalized steady-state EPS could reach ~₹115-120/share compared to normalized baseline FY26 EPS of ~₹50-52/share, representing a ~125% EPS uplift.

3. Fundamental & Multibagger Quality Evaluation

• Revenue & Margins: Consolidated results were severely depressed by European subsidiary losses (-₹62 Cr PAT in Dec 2025 quarter). However, with the court-approved liquidation/takeover of French subsidiaries by MBDA and SII, the loss-making drag is eliminated, unmasking strong domestic performance (25.4% standalone revenue growth in FY26).
• ROCE & Capital Allocation: Standalone ROCE remains robust at 19.0%. Debt-to-Equity is low at 0.28.
• Promoter Holding: Stable at 46.88% with no pledging issues noted.

4. Valuation & Scenario Framework (36-48 Month Horizon)

• Base Case (+45%): Successful execution of ₹500 Cr capex on schedule. Normalized EPS reaches ₹110 by FY29. Target P/E of 50x gives a target price of ₹5,500.
• Bull Case (+90%): Accelerated defense procurement, rapid ramp of HAL AESA Radar and BTS orders, expanding OPM to 18%. EPS reaches ₹135 by FY29. Multiplier re-rates to 55x, giving target price of ₹7,425.
• Bear Case (-25%): Delays in plant commissioning and higher working capital lockup. Normalized EPS reaches ₹70. Valuation compresses to 40x P/E, yielding a price of ₹2,800.

5. Verdict Rationale

Centum Electronics presents a credible turnaround and scale-up story. The shedding of loss-making French assets combined with a massive ₹500 Cr expansion into high-margin domestic Strategic Electronics positions the company well for long-term growth. However, given that this is a 4-year proposed capex commitment and the stock has already appreciated 61.5% in the last 6 months (P/B 14.2x), the near-term risk-reward is balanced. It earns a POSSIBLE multibagger verdict with a score of 62.

1. Ramp-Aware Impact Math

Centum Electronics has secured a major order from HAL valued at INR 566 Cr. The order is structured in two distinct phases: * Phase 1: INR 66 Cr over 2 years (INR 33 Cr/year). * Phase 2: INR 500 Cr over 5 years (INR 100 Cr/year).

Year-1 Revenue Uplift: In Year 1, we assume Phase 1 is active (INR 33 Cr) and Phase 2 begins its initial ramp (assuming 20% of its annual run-rate, or INR 20 Cr). Total Year-1 incremental revenue is estimated at INR 53 Cr. Compared to the TTM consolidated revenue of INR 1,170 Cr, this represents a 11.37% year-1 revenue uplift.

Steady-State Revenue Uplift: Once both phases are fully operational, the combined annual run-rate will be INR 133 Cr (INR 33 Cr from Phase 1 + INR 100 Cr from Phase 2). This represents a 11.37% steady-state revenue uplift on TTM revenue. However, if Phase 1 concludes before Phase 2 reaches peak execution, the steady-state annual run-rate from Phase 2 alone is INR 100 Cr, representing an 8.55% steady-state revenue uplift.

Profitability Impact: Centum's standalone EBITDA margins are healthy at 13.48% (FY25), but consolidated PAT is currently negative (INR -32 Cr TTM) due to overseas subsidiary losses in France and Canada. Assuming the domestic HAL order operates at a mature standalone OPM of 14%, the steady-state incremental EBITDA from this order would be ~INR 14 Cr per year. If the company successfully divests/restructures its loss-making overseas subsidiaries, this incremental domestic operating profit will flow directly to the bottom line, driving a sharp turnaround from negative to positive EPS.

2. Industry Capital-Intensity & Expected CAGR

• Capital Intensity: Medium. While design and engineering are asset-light, manufacturing safety-critical aerospace systems requires specialized testing equipment and cleanrooms. The company is investing INR 34.97 Cr from QIP and building a new KIADB facility.
• Execution Difficulty: High. Defense electronics require stringent qualifications, certifications, and long testing cycles. Delays in government clearances or component sourcing can defer revenue recognition.
• Expected Industry CAGR: 20% structural growth driven by India's defense indigenization (Atmanirbhar Bharat) and space sector expansion.

3. Multibagger Quality Assessment

• Strengths: Strong technical moat with 600 design engineers and 17 patents. High switching costs in safety-critical applications. Standalone business is highly profitable.
• Weaknesses: Consolidated performance is severely dragged down by international operations. Promoter holding has declined to 46.89%. High working capital cycle typical of defense contracts.

4. Valuation & Scenarios

• Base Case (45% Upside): Successful execution of Phase 1 and initial ramp of Phase 2. Overseas subsidiary losses are halved through restructuring. Consolidated PAT turns positive (INR 25-30 Cr), leading to a re-rating towards peer median multiples (60.9x P/E).
• Bull Case (90% Upside): Complete divestment of the Canadian subsidiary and turnaround of the French business. Domestic defense execution accelerates, and the company achieves a consolidated PAT of >INR 50 Cr. The stock undergoes a massive re-rating as a pure-play Indian defense electronics leader.
• Bear Case (-30% Downside): Execution delays in the HAL order, prolonged restructuring in Europe, and further equity dilution or promoter selling. Consolidated losses persist.

5. Verdict Rationale

Centum is a classic 'turnaround + high-growth niche' candidate. The HAL order provides strong revenue visibility, but the multi-year execution timeline (up to 5 years) means the impact will be gradual rather than immediate. The key catalyst for a multibagger trajectory is not just order wins, but the successful elimination of overseas subsidiary drag. Until consolidated profitability is restored, the verdict is capped at 'POSSIBLE'.

1. Catalyst & Ramp-Aware Impact Math

Centum Electronics has secured a Phase-1 design and development order from HAL worth ₹66 Cr (excluding GST) to be executed over 2 years (FY27-FY28). This translates to an annual revenue contribution of ₹33 Cr, representing a 2.8% year-1 revenue uplift relative to TTM consolidated revenue of ₹1,170 Cr.

The real value lies in the indicative Phase-2 serial production order of ₹500 Cr, expected to be executed over 5 years post-Phase-1. Assuming Phase-1 completes successfully, Phase-2 will generate approximately ₹100 Cr annually. This represents a 8.5% steady-state annual revenue uplift.

While the near-term revenue impact is modest, the strategic value is high. Centum's standalone EBITDA margins are healthy (~13.5%), but consolidated margins are dragged to 0% PAT due to overseas losses. If Centum successfully executes its planned divestment of the Canadian and European subsidiaries, the domestic business (boosted by this high-margin HAL order) will drive a massive turnaround in consolidated EPS. However, because current consolidated EPS is negative (₹-18.28), a traditional P/E-based EPS uplift percentage is not mathematically meaningful at this stage.

2. Industry Capital Intensity & Execution Difficulty

The defense electronics and aerospace components industry has Medium Capital Intensity but High Execution Difficulty. R&D cycles are long, and qualification standards are stringent. Working capital cycles are typically stretched due to government/defense payment milestones. This means order-to-revenue conversion is slow, and cash flows can be lumpy.

3. Multibagger Quality Assessment

• Financials: TTM revenue is ₹1,170 Cr, but consolidated PAT is negative (₹-32 Cr). Standalone operations are profitable and growing, but the consolidated entity is severely weighed down. ROCE is respectable at 17.0%, and D/E is low at 0.17.
• Promoter Holding: Decreased from 51.52% to 46.89% in late 2025, which is a minor red flag and caps near-term sentiment.
• Moat: Strong. Centum is a single-source supplier for safety-critical applications with high switching costs.

4. Scenario Analysis (24-48 Months)

• Bull Case (+90%): Successful divestment of loss-making foreign subsidiaries by FY27; Phase-1 HAL order executes ahead of schedule; domestic SEBU margins expand to >15%; consolidated PAT turns strongly positive, leading to a massive re-rating in line with defense peers (median P/E ~60x).
• Base Case (+45%): Foreign subsidiaries are gradually restructured or partially divested; HAL Phase-1 executes on time; consolidated EPS turns marginally positive by FY28.
• Bear Case (-25%): Divestment of foreign subsidiaries faces delays or high write-offs; HAL order faces execution delays; working capital cycle stretches, requiring further debt or dilution.

5. Verdict Rationale

Centum is a classic 'turnaround' candidate rather than a steady-state compounder. The HAL order validates its high-end technical capabilities in the lucrative Indian defense ecosystem. If management successfully cleans up the global balance sheet, the domestic business has the structural tailwinds (20% industry CAGR) to drive a multibagger trajectory. However, due to current consolidated losses and the recent promoter dilution, the verdict is capped at POSSIBLE with a score of 65.